Kai Li received his bachelor's and master's degrees in Biology from Harbin Institute of Technology, then he pursued his PhD research in immunology and cancer in the Professor Akinori Takaoka group at Institute for Genetic Medicine, Hokkaido University in Japan. He returned to Harbin Institute of Technology to do postdoctoral research after completing his PhD degree in 2016, and now he is an associate professor at this institute. His research interests are in the interdisciplinary field of materials science, molecular biology, and clinical medicine, with a focus on tumor precision diagnosis and treatment, immune regulation mechanisms, and the development of novel nanomaterials for biomedical applications. He has developed multifunctional nanomaterials for targeted cancer therapy and dynamic monitoring, elucidated epigenetic mechanisms underlying tumor chemoresistance, and explored the dual functions of innate immune pathways in antiviral and antitumor immunity. Overall, his work aims to advance precision medicine and improve therapeutic outcomes for patients.
Kai Li received his bachelor's and master's degrees in Biology from Harbin Institute of Technology, then he pursued his PhD research in immunology and cancer in the Professor Akinori Takaoka group at Institute for Genetic Medicine, Hokkaido University in Japan. He returned to Harbin Institute of Technology to do postdoctoral research after completing his PhD degree in 2016, and now he is an associate professor at this institute. His research interests are in the interdisciplinary field of materials science, molecular biology, and clinical medicine, with a focus on tumor precision diagnosis and treatment, immune regulation mechanisms, and the development of novel nanomaterials for biomedical applications. He has developed multifunctional nanomaterials for targeted cancer therapy and dynamic monitoring, elucidated epigenetic mechanisms underlying tumor chemoresistance, and explored the dual functions of innate immune pathways in antiviral and antitumor immunity. Overall, his work aims to advance precision medicine and improve therapeutic outcomes for patients.